查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1392002

細菌性唾液腺炎市場：依類型、細菌類型、腺體類型、藥物類別、配銷通路、地區

Bacterial Sialadenitis Market, By Type, By Type of Bacteria, By Gland Type, By Drug Class, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 130 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

細菌性唾液腺炎的全球市場規模預計將從 2023 年的 4.678 億美元增加到 2030 年的 6.644 億美元，預測期內複合年成長率為 5.1%。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 4.678 億美元
實績資料 2018-2021 預測期 2023-2030
預測期複合年成長率 5.10% 2030年市場規模預測 6.644 億美元
圖 1. 2023 年細菌性涎腺炎的全球市場佔有率（%），依地區分類
細菌性涎腺炎市場-IMG1

唾液腺炎是主要唾液腺腫脹或腫大：腮腺（雙耳前面）、下頷腺（口腔底部、舌下）和舌下腺（口腔後部、舌下） 。它可以是急性的（突然的）、慢性的（長期的）或復發性的。這種情況是由唾液腺導管感染或阻塞引起的。金黃色葡萄球菌是細菌性唾液腺炎的常見原因，但其他微生物也可能引起此疾病。細菌性唾液腺炎通常會帶來疼痛，並可能包括發燒和發冷。受影響的唾液腺腫脹、發紅、觸痛，並且通常在中心變色，這可能表示膿腫。

預防措施包括良好的口腔衛生、多喝水以及解決增加細菌性唾液腺炎風險的潛在疾病。可以透過定期進行牙科護理並避免危險因素來降低患這種疾病的機會。細菌性唾液腺炎的主要治療方法是針對引起感染的特定細菌的抗生素治療。也建議充足的水分、熱敷和唾液腺依摩，以促進唾液流動並緩解症狀。在某些情況下，可能需要手術干預來去除唾液腺結石或排放膿腫。

市場動態：

由於唾液腺感染疾病、唾液腺炎和修格蘭氏症候群自體自體免疫疾病的盛行率不斷上升，預計全球細菌性唾液腺炎市場在未來幾年將顯著成長。

預計高昂的治療成本和與感染相關的併發症將阻礙全球細菌性唾液腺炎市場的成長。

本研究的主要特點

  • 該報告對全球細菌性唾液腺炎市場進行了詳細分析，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（CAGR%）。
  • 它還揭示了各個區隔市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
  • 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
  • 它根據公司亮點、產品系列、主要亮點、績效和策略等參數，介紹了全球細菌性唾液腺炎市場的主要企業。
  • 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的資訊。
  • 全球細菌性涎腺炎市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員可以透過用於分析全球細菌性唾液腺炎市場的各種策略矩陣來促進他們的決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 假設
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章市場動態、法規及趨勢分析

  • 市場動態
  • 影響分析
  • 主要亮點
  • 監管場景
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 併購場景

第4章細菌性唾液腺炎市場 -冠狀病毒（COVID-19）大流行的影響

  • 新型冠狀病毒感染疾病（COVID-19）的流行病學
  • 供需面分析
  • 經濟影響

第5章細菌性唾液腺炎市場，依類型，2018-2030

  • 急性
  • 慢性的

第6章細菌性唾液腺炎市場，依細菌型，2018-2030

  • 金黃色葡萄球菌
  • 草綠色鏈球菌
  • 銅綠假單胞菌
  • 大腸桿菌
  • 其他

第 7 章 細菌性唾液腺炎市場，依腺體類型，2018-2030

  • 副狀
  • 顎下
  • 舌下

第 8 章細菌性唾液腺炎市場，依藥物類別，2018-2030

  • 抗生素
  • 雙氯西林
  • 頭孢菌素
  • 克林黴素

第 9 章細菌性唾液腺炎市場，依配銷通路，2018-2030

  • 醫院藥房
  • 零售藥房
  • 電子商務

第10章細菌性唾液腺炎市場，依地區，2018-2030

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中東
  • GCC
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 南非
  • 中部非洲

第11章競爭形勢

  • Pfizer Inc.
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Sanofi SA
  • Johnson & Johnson
  • Abbott Laboratories
  • Eli Lilly and Company
  • AstraZeneca plc.
  • Bayer AG

第12章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI5810

The global bacterial sialadenitis market size is projected to reach US$ 664.4 million by 2030, from US$ 467.8 million in 2023, growing at a CAGR of 5.1% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 467.8 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 5.10% 2030 Value Projection: US$ 664.4 Mn
Figure 1. Global Bacterial sialadenitis Market Share (%), by Region, 2023
Bacterial Sialadenitis Market - IMG1

Sialadenitis is swelling and enlargement of the major salivary glands, the parotid (in front of each ear), submandibular (under the tongue on the floor of the mouth) or sublingual (below the tongue in the back of the mouth). It can be acute (sudden) or chronic (long-term) or recurrent. The condition can be caused by infection or by a blockage of the gland's ducts. A common cause of bacterial sialadenitis is Staphylococcus aureus, but other organisms may also be responsible. Bacterial sialadenitis is usually painful and may be accompanied by fever and chills. The affected gland is swollen, red and tender and usually has a central area of discoloration, which may indicate an abscess.

Preventive measures include maintaining good oral hygiene, drinking enough water, and addressing underlying conditions that increase the risk of bacterial sialadenitis. Regular dental care and avoiding risk factors can help reduce the likelihood of developing the condition. The primary treatment for bacterial sialadenitis is antibiotic therapy to target the specific bacteria causing the infection. Adequate hydration, warm compresses, and gland massage may also be recommended to promote saliva flow and relieve symptoms. In some cases, surgical intervention may be necessary to remove salivary stones or drain abscesses.

Market Dynamics:

The global bacterial sialadenitis market is expected to witness significant growth in the coming years owing to rising incidence of conditions such as salivary gland infections, sialadenitis, and autoimmune diseases such as Sjogren's syndrome.

High cost of treatment and complications associated with the infection are expected to hinder growth of the global bacterial sialadenitis market over the forecast.

Key features of the study:

  • This report provides an in-depth analysis of the global bacterial sialadenitis market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global bacterial sialadenitis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc, Novartis AG, Sanofi S.A., Johnson & Johnson, Abbott Laboratories, Eli Lilly and Company, AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Roche Holding AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., and Allergan plc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global bacterial sialadenitis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bacterial sialadenitis market

Detailed Segmentation:

  • By Type:
    • Acute
    • Chronic
  • Type of Bacteria:
    • Staphylococcus aureus
    • Streptococcus viridans
    • Pseudomonas aeruginosa
    • Escherichia coli
    • Others (Haemophilus influenza, etc.)
  • By Gland Type:
    • Parotid
    • Submandibular
    • Sublingual
  • By Drug Class
    • Antibiotics
    • Dicloxacillin
    • Cephalosporin
    • Clindamycin
    • Analgesics
  • By Distribution Channel:
    • Hospitals Pharmacies
    • Retail Pharmacies
    • Ecommerce
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • Latin America
  • Company Profiles:
    • Pfizer Inc.
    • Merck & Co., Inc.
    • GlaxoSmithKline plc
    • Novartis AG
    • Sanofi S.A.
    • Johnson & Johnson
    • Abbott Laboratories
    • Eli Lilly and Company
    • AstraZeneca plc
    • Bayer AG
    • Bristol-Myers Squibb Company
    • Roche Holding AG
    • Teva Pharmaceutical Industries Ltd.
    • Mylan N.V.
    • Allergan plc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Bacterial Sialadenitis Market, By Type
    • Market Bacterial Sialadenitis Market, By Type of Bacteria
    • Market Bacterial Sialadenitis Market, By Gland Type
    • Market Bacterial Sialadenitis Market, By Drug Class
    • Market Bacterial Sialadenitis Market, By Distribution Channel
    • Market Bacterial Sialadenitis Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Bacterial Sialadenitis Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Bacterial Sialadenitis Market, By Type, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Acute
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Chronic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

6. Bacterial Sialadenitis Market, By Type of Bacteria, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Staphylococcus aureus
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Streptococcus viridans
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Pseudomonas aeruginosa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Escherichia coli
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

7. Bacterial Sialadenitis Market, By Gland Type, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019- 2030
    • Segment Trends
  • Paratoid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Submandibular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Sublingual
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

8. Bacterial Sialadenitis Market, By Drug Class, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019- 2030
    • Segment Trends
  • Antibiotics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Dicloxacillin
  • Cephalosporin
  • Clindamycin
    • Analgesic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

9. Bacterial Sialadenitis Market, By Distribution Channel, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019- 2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Ecommerce
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

10. Bacterial Sialadenitis Market, By Region, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2019-2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Mn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Mn)
  • North Africa
  • South Africa
  • Central Africa

11. Competitive Landscape

  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Sanofi S.A.
  • Johnson & Johnson
  • Abbott Laboratories
  • Eli Lilly and Company
  • AstraZeneca plc.
  • Bayer AG
  • Analyst Views

12. Section

  • Research Methodology
  • About us